| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Moriarty John B | Chief Legal Officer | C/O AVIDITY BIOSCIENCES, INC., 3020 CALLAN ROAD, SAN DIEGO | /s/ Michael F. MacLean, Attorney-in-Fact | 19 Dec 2025 | 0001564621 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RNA | Common Stock | Award | $0 | +56,000 | +117% | $0.000000 | 103,755 | 17 Dec 2025 | Direct | F1 |
| transaction | RNA | Common Stock | Tax liability | $1,927,841 | -26,824 | -26% | $71.87 | 76,931 | 17 Dec 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents shares acquired upon the vesting of performance-based restricted stock units (PSUs). Each PSU represented a contingent right to receive one share of the Issuer's common stock. The PSUs were originally granted to the Reporting Person on October 30, 2024. The PSUs were accelerated and settled on December 17, 2025 for tax planning purposes and such shares remain subject to recoupment by the Issuer if the Reporting Person's employment is terminated by the Issuer for cause or by the Reporting Person without good reason. |
| F2 | Represents the number of shares withheld by the Issuer to cover tax withholding in connection with the settlement of PSUs on December 17, 2025. |